title: In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives?
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
authors.forename: Anders
authors.initials: A
authors.lastname: Himmelman
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D006973:Hypertension / Q000097:blood / Q000150:complications*; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin